Cadila Healthcare informs about press release

20 Nov 2018 Evaluate

Cadila Healthcare has informed about submission of a copy of press release dated November 20, 2018 titled ‘Zydus receives tentative approval from the USFDA for Deferasirox Tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

920.90 -10.55 (-1.13%)
08-Dec-2025 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1790.05
Dr. Reddys Lab 1272.70
Cipla 1498.90
Zydus Lifesciences 920.90
Lupin 2061.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×